| |
Mortality per 100,000
|
Total study periodc
|
Period 1
|
Period 2
|
Period 3
|
Period 4
|
Period 5
|
|---|
| |
1983
|
2013
|
Average APC (%)
|
95%CI
|
Years
|
APC (%)
|
Years
|
APC (%)
|
Years
|
APC (%)
|
Years
|
APC (%)
|
Years
|
APC (%)
|
|---|
|
Cancer
|
|
Lung
|
|
Male
|
165.7
|
77.2
|
−2.6a
|
−2.8, −2.4
|
1983–1991
|
−2.0a
|
1991–1997
|
−3.8a
|
1997–2004
|
−2.9a
|
2004–2008
|
−1.1a
|
2008–2013
|
−2.5a
|
|
Female
|
39.9
|
50.7
|
0.7a
|
0.5, 1.0
|
1983–1989
|
2.4a
|
1989–2004
|
0.1
|
2004–2008
|
2.1a
|
2008–2013
|
−0.5
| | |
|
Colorectal
|
|
Male
|
54.0
|
35.3
|
−1.5a
|
−1.9, −1.0
|
1983–1992
|
−0.3
|
1992–1995
|
−3.7
|
1995–2013
|
−1.6a
| | | | |
|
Female
|
38.9
|
22.8
|
−2.1a
|
−2.2, −1.9
|
1983–2013
|
−2.1a
| | | | | | | | |
|
Prostate
|
|
Male
|
43.7
|
46.8
|
0.1
|
−0.1, 0.3
|
1983–1992
|
3.0a
|
1992–2013
|
−1.2a
| | | | | | |
|
Breast
|
|
Female
|
56.2
|
35.5
|
−1.5a
|
−1.8, −1.2
|
1983–1985
|
2.6
|
1985–1991
|
−0.4
|
1991–1998
|
−2.9a
|
1998–2002
|
−1.3
|
2002–2013
|
−2.1a
|
|
Cardiovascular Diseases
|
|
Ischaemic Heart Disease
|
|
Male
|
622.1
|
177.2
|
−4.1a
|
−4.5, −3.7
|
1983–1985
|
−0.2
|
1985–1993
|
−2.5a
|
1993–2002
|
−4.4a
|
2002–2011
|
−6.2a
|
2011–2013
|
−3.3
|
|
Female
|
306.2
|
86.5
|
−4.1a
|
−4.5, −3.8
|
1983–1985
|
1.0
|
1985–1993
|
−2.0a
|
1993–2003
|
−4.5a
|
2003–2011
|
−7.0a
|
2011–2013
|
−3.8
|
|
Stroke
|
|
Male
|
213.4
|
70.0
|
−3.7a
|
−4.5, −2.9
|
1983–1985
|
2.0
|
1985–1998
|
−3.4a
|
1998–2002
|
0.3
|
2002–2013
|
−6.5a
| | |
|
Female
|
199.1
|
67.9
|
−3.5a
|
−4.1, −3.0
|
1983–1985
|
1.1
|
1985–1997
|
−3.2a
|
1997–2003
|
−1.0
|
2003–2013
|
−6.3a
| | |
|
Other CVD
|
|
Male
|
180.2
|
69.0
|
−2.9a
|
−3.7, −2.1
|
1983–1991
|
−4.4a
|
1991–1995
|
3.6
|
1995–2013
|
−3.6a
| | | | |
|
Female
|
140.0
|
58.1
|
−2.6a
|
−3.5, −1.7
|
1983–1991
|
−5.2a
|
1991–1995
|
3.8
|
1995–2013
|
−2.8a
| | | | |
-
aSignificantly different from zero (p < 0.05)
-
b Standardised to the 2013 European standard population by 5-year age groups
-
c Years 1983 to 2013
-
APC, annual percent change